Benefits of rivastigmine on attention in dementia ... [Neurology. 2005] - PubMed

loading

Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items. [Am J Alzheimers Dis Other Deme...]
Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.
Schmitt FA, Aarsland D, Brønnick KS, Meng X, Tekin S, Olin JT. Am J Alzheimers Dis Other Demen. 2010 Aug; 25(5):407-13. Epub 2010 Apr 14.
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. [Mov Disord. 2006]
Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
Poewe W, Wolters E, Emre M, Onofrj M, Hsu C, Tekin S, Lane R, EXPRESS Investigators. Mov Disord. 2006 Apr; 21(4):456-61.
Rivastigmine for dementia associated with Parkinson's disease. [Curr Neurol Neurosci Rep. 2005]
Rivastigmine for dementia associated with Parkinson's disease.
Morgan J, Sethi KD. Curr Neurol Neurosci Rep. 2005 Jul; 5(4):263-5.
Review Rivastigmine in Parkinson's disease dementia. [Expert Opin Drug Metab Toxicol...]
Review Rivastigmine in Parkinson's disease dementia.
Chitnis S, Rao J. Expert Opin Drug Metab Toxicol. 2009 Aug; 5(8):941-55.
Review Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease. [Drugs Today (Barc). 2007]
Review Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
Wesnes K. Drugs Today (Barc). 2007 Jun; 43(6):349-59.

Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery. [BMC Neurol. 2011]
Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
Edgar C, Jongen PJ, Sanders E, Sindic C, Goffette S, Dupuis M, Jacquerye P, Guillaume D, Reznik R, Wesnes K. BMC Neurol. 2011 Jun 7; 11:68. Epub 2011 Jun 7.
Review Cognitive enhancement by drugs in health and disease. [Trends Cogn Sci. 2011]
Review Cognitive enhancement by drugs in health and disease.
Husain M, Mehta MA. Trends Cogn Sci. 2011 Jan; 15(1):28-36. Epub 2010 Dec 9.
The effect of modafinil on cognitive function in breast cancer survivors. [Cancer. 2009]
The effect of modafinil on cognitive function in breast cancer survivors.
Kohli S, Fisher SG, Tra Y, Adams MJ, Mapstone ME, Wesnes KA, Roscoe JA, Morrow GR. Cancer. 2009 Jun 15; 115(12):2605-16.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Benefits of rivastigmine on attention in dementia associated with Parkinson dise...
Benefits of rivastigmine on attention in dementia associated with Parkinson disease.
Neurology. 2005 Nov 22 ;65(10):1654-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed